BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37238955)

  • 1. Efficacy and Safety of Anticoagulant Therapy in COVID-19-Related Pulmonary Embolism with Different Extension.
    Gatto MC; Oliva A; Palazzolo C; Picariello C; Garascia A; Nicastri E; Girardi E; Antinori A
    Biomedicines; 2023 Apr; 11(5):. PubMed ID: 37238955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung perfusion assessed by SPECT/CT after a minimum of three months anticoagulation therapy in patients with SARS-CoV-2-associated acute pulmonary embolism: a retrospective observational study.
    Berghaus TM; Bader S; Faul C; Haberl S; Schwarz F; Liebich A; Dierks A; Kircher M; Lapa C; Pfob CH
    Respir Res; 2022 Oct; 23(1):296. PubMed ID: 36316693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Embolism in Hospitalized Patients with COVID-19: A Multicenter Study.
    Riyahi S; Dev H; Behzadi A; Kim J; Attari H; Raza SI; Margolis DJ; Jonisch A; Megahed A; Bamashmos A; Elfatairy K; Prince MR
    Radiology; 2021 Dec; 301(3):E426-E433. PubMed ID: 34254850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute pulmonary embolism in hospitalized patients with SARS-CoV-2-related pneumonia: multicentric experience from Italian endemic area.
    Ippolito D; Giandola T; Maino C; Pecorelli A; Capodaglio C; Ragusi M; Porta M; Gandola D; Masetto A; Drago S; Allegranza P; Corso R; Talei Franzesi C; Sironi S
    Radiol Med; 2021 May; 126(5):669-678. PubMed ID: 33417194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis.
    Mestre-Gómez B; Lorente-Ramos RM; Rogado J; Franco-Moreno A; Obispo B; Salazar-Chiriboga D; Saez-Vaquero T; Torres-Macho J; Abad-Motos A; Cortina-Camarero C; Such-Diaz A; Ruiz-Velasco E; Churruca-Sarasqueta J; Muñoz-Rivas N;
    J Thromb Thrombolysis; 2021 Jan; 51(1):40-46. PubMed ID: 32613385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between pulmonary embolism and COVID-19 severe pneumonia: Experience from two centers in the core of the infection Italian peak.
    Valle C; Bonaffini PA; Dal Corso M; Mercanzin E; Franco PN; Sonzogni A; Vacca G; Gianatti A; Sironi S
    Eur J Radiol; 2021 Apr; 137():109613. PubMed ID: 33657476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin versus direct oral anticoagulants for patients needing distal deep vein thrombosis treatment.
    Pham A; Heib A; Goodman E; Cotto R; Jafari P; Lipsitz E; Indes J
    J Vasc Surg Venous Lymphat Disord; 2022 Jul; 10(4):826-831.e1. PubMed ID: 35124243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central pulmonary embolism in patients with Covid-19.
    Nordberg M; Bankler S; Everhov ÅH; Saraste D
    Infect Dis (Lond); 2021 Jul; 53(7):513-520. PubMed ID: 33682582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
    Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
    Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antithrombotic Treatment of Pulmonary Embolism].
    Ebner M; Lankeit M
    Dtsch Med Wochenschr; 2020 Jul; 145(14):970-977. PubMed ID: 32668468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications in COVID-19 patients: Characteristics of pulmonary embolism.
    Cau R; Pacielli A; Fatemeh H; Vaudano P; Arru C; Crivelli P; Stranieri G; Suri JS; Mannelli L; Conti M; Mahammedi A; Kalra M; Saba L
    Clin Imaging; 2021 Sep; 77():244-249. PubMed ID: 34029929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of pulmonary embolism in patients with COVID-19 pneumonia and high D-dimer values: A prospective study.
    Alonso-Fernández A; Toledo-Pons N; Cosío BG; Millán A; Calvo N; Ramón L; de Mendoza SH; Morell-García D; Bauça-Rossello JM; Núñez B; Pons J; Palmer JA; Martín L; Peñaranda M; Pou JA; Sauleda J; Sala-Llinas E
    PLoS One; 2020; 15(8):e0238216. PubMed ID: 32841275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary embolism in COVID-19 patients: a French multicentre cohort study.
    Fauvel C; Weizman O; Trimaille A; Mika D; Pommier T; Pace N; Douair A; Barbin E; Fraix A; Bouchot O; Benmansour O; Godeau G; Mecheri Y; Lebourdon R; Yvorel C; Massin M; Leblon T; Chabbi C; Cugney E; Benabou L; Aubry M; Chan C; Boufoula I; Barnaud C; Bothorel L; Duceau B; Sutter W; Waldmann V; Bonnet G; Cohen A; Pezel T;
    Eur Heart J; 2020 Jul; 41(32):3058-3068. PubMed ID: 32656565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing pulmonary embolism from presentation to extended treatment.
    Cohen AT; Dobromirski M; Gurwith MM
    Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood test dynamics in hospitalized COVID-19 patients: Potential utility of D-dimer for pulmonary embolism diagnosis.
    Cerdà P; Ribas J; Iriarte A; Mora-Luján JM; Torres R; Del Río B; Jofre HI; Ruiz Y; Huguet M; Fuset MP; Martínez-Yélamos S; Santos S; Llecha N; Corbella X; Riera-Mestre A
    PLoS One; 2020; 15(12):e0243533. PubMed ID: 33370304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients.
    Thoreau B; Galland J; Delrue M; Neuwirth M; Stepanian A; Chauvin A; Dellal A; Nallet O; Roriz M; Devaux M; London J; Martin-Lecamp G; Froissart A; Arab N; Ferron B; Groff MH; Queyrel V; Lorut C; Regard L; Berthoux E; Bayer G; Comarmond C; Lioger B; Mekinian A; Szwebel TA; Sené T; Amador-Borrero B; Mangin O; Sellier PO; Siguret V; Mouly S; Kevorkian JP; Lariboisière Covid Group ; Vodovar D; Sene D
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33926038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT imaging of pulmonary embolism in patients with COVID-19 pneumonia: a retrospective analysis.
    Espallargas I; Rodríguez Sevilla JJ; Rodríguez Chiaradía DA; Salar A; Casamayor G; Villar-Garcia J; Rodó-Pin A; Marsico S; Carbullanca S; Ramal D; Del Carpio LA; Gayete Á; Maiques JM; Zuccarino F
    Eur Radiol; 2021 Apr; 31(4):1915-1922. PubMed ID: 32964337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60.
    Anand SS
    Vasc Med; 2001 Nov; 6(4):269-70. PubMed ID: 11958396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of acute pulmonary embolism using anticoagulation therapy alone in coronavirus disease 2019.
    Ritchie CA; Johnson MM; Stowell JT; Idrees H; Toskich B; Paz-Fumagalli R; Montazeri S; Fortich S; Franco-Mesa C; Gloviczki P; Bjarnason H; Rivera C; Shaikh M; Moreno-Franco P; Sanghavi D; Marquez CP; McBane RD; Park MS; O'Horo JC; Meschia JF; Erben Y
    J Vasc Surg Venous Lymphat Disord; 2022 May; 10(3):578-584.e2. PubMed ID: 35085829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary embolism risk factors for intensive care unit anticoagulated COVID-19 patients undergoing computed tomography angiography.
    Briceño-Mayorga GP; Gutiérrez R; Sotomayor C; Ebner M; Allende F; Assar R
    Rev Bras Ter Intensiva; 2021; 33(3):346-352. PubMed ID: 35107545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.